Eton Pharmaceuticals Inc. (NASDAQ: ETON) Stock Information | RedChip

Eton Pharmaceuticals Inc. (NASDAQ: ETON)


$12.6800
+0.0200 ( +1.52% ) 34.6K

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

Market Data


Open


$12.6800

Previous close


$12.6600

Volume


34.6K

Market cap


$329.81M

Day range


$11.3850 - $12.7310

52 week range


$3.0300 - $13.9800

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Oct 08, 2024
4 Insider transactions 1 Oct 04, 2024
8-k 8K-related 15 Oct 03, 2024
3 Insider transactions 1 Sep 12, 2024
4 Insider transactions 1 Sep 12, 2024
8-k 8K-related 15 Aug 08, 2024
10-q Quarterly Reports 61 Aug 08, 2024
8-k/a 8K-related 14 Aug 02, 2024
8-k 8K-related 15 Jul 15, 2024
8-k 8K-related 15 Jun 21, 2024

Latest News